Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
A Study Comparing Quality of Life in Patients Undergoing a Non-Myeloablative Versus a Myeloablative Peripheral Blood Stem Cell Transplant for Hematological Diseases
2 other identifiers
observational
106
1 country
1
Brief Summary
This study will examine the quality of life of patients undergoing bone marrow transplantation to treat a blood disease. It will look at how this therapy affects many areas of life, including for example, personal relationships, work, and general emotional state. The information gained may lead to improved ways of dealing with problems that may arise before or during treatment. Patients receiving bone marrow stem cells donated by a family member may participate in this study. They will be interviewed before treatment begins and will complete questionnaires at the following intervals:
- 1.day of admission to the hospital
- 2.day of the transplant
- 3.30 days after the transplant
- 4.100 days after the transplant
- 5.1 year after therapy
- 6.2 years after therapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 1999
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 1999
CompletedFirst Submitted
Initial submission to the registry
March 22, 2000
CompletedFirst Posted
Study publicly available on registry
March 23, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2004
CompletedMarch 4, 2008
October 1, 2004
March 22, 2000
March 3, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Male or female subjects 18 years of age or older.
- Able to read English or Spanish.
- Hematological disease requiring A-PBSCT.
- Signed informed consent for QOL study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Warren G. Magnuson Clinical Center (CC)
Bethesda, Maryland, 20892, United States
Related Publications (3)
Andrykowski MA, Henslee PJ, Farrall MG. Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1989 Jan;4(1):75-81.
PMID: 2647190BACKGROUNDAndrykowski MA, Altmaier EM, Barnett RL, Otis ML, Gingrich R, Henslee-Downey PJ. The quality of life in adult survivors of allogeneic bone marrow transplantation. Correlates and comparison with matched renal transplant recipients. Transplantation. 1990 Sep;50(3):399-406. doi: 10.1097/00007890-199009000-00009.
PMID: 2402788BACKGROUNDBaker F, Wingard JR, Curbow B, Zabora J, Jodrey D, Fogarty L, Legro M. Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant. 1994 May;13(5):589-96.
PMID: 8054912BACKGROUND
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
March 22, 2000
First Posted
March 23, 2000
Study Start
October 1, 1999
Study Completion
October 1, 2004
Last Updated
March 4, 2008
Record last verified: 2004-10